Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 35,233 | 218,505 | 10,393 | 4,589 | 7,588 |
| Cost of Goods | 8,241 | 9,640 | 1,709 | 959 | 1,503 |
| Gross Profit | 26,992 | 208,865 | 8,684 | 3,630 | 6,085 |
| Operating Expenses | 176,231 | 121,405 | 85,278 | 69,929 | 29,725 |
| Operating Income | -148,998 | 88,100 | -75,885 | -65,340 | -23,137 |
| Interest Expense | 0 | 0 | 0 | 0 | 20 |
| Other Income | 51,510 | 16,016 | 2,716 | 1,938 | 346 |
| Pre-tax Income | -97,488 | 104,116 | -73,169 | -63,402 | -22,811 |
| Income Tax | -2,755 | 4,179 | N/A | -435 | N/A |
| Net Income Continuous | -94,733 | 99,937 | -73,169 | -62,967 | -22,811 |
| Net Income | $-94,733 | $99,937 | $-73,169 | $-62,967 | $-22,811 |
| EPS Basic Total Ops | -2.58 | 2.99 | -2.45 | -2.38 | -2.59 |
| EPS Basic Continuous Ops | -2.58 | 2.99 | -2.45 | -2.38 | -2.49 |
| EPS Diluted Total Ops | -2.58 | 2.73 | -2.45 | -2.38 | -2.59 |
| EPS Diluted Continuous Ops | -2.58 | 2.73 | -2.45 | -2.38 | -2.49 |
| EPS Diluted Before Non-Recurring Items | -3.26 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-143,042 | $92,837 | $-71,384 | $-62,792 | $-22,746 |